Search results
Bull Market and Beyond: 3 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 6 days agoThe S&P 500 rose to a record high earlier this year, confirming its presence in a bull market, and...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 4 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
InvestorPlace via Yahoo Finance· 6 days agoOn Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 3 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 3 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 7 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA TODAY via Yahoo News· 6 days agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 6 days agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...